For job opportunities see our webpage at http://www.nicoyalife.com/careers/
Location: Canada, Ontario, Kitchener
Employees: 51-200
Phone: +1 877-673-6777
Total raised: $14.57M
Founded date: 2012
Investors 7
Funding Rounds 3
| Date | Series | Amount | Investors |
| 14.01.2020 | Series A | $10M | - |
| 03.05.2019 | - | $2.57M | - |
| 30.01.2018 | - | $2M | - |
Mentions in press and media 15
| Date | Title | Description |
| 19.05.2022 | Surface Plasmon Resonance Market is Extrapolated to Reach a Value of USD 1.5 Bn by 2029 | NEWARK, Del, May 19, 2022 (GLOBE NEWSWIRE) -- Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective nature. Additionally, the availability of versatile products coupled with... |
| 19.05.2022 | Surface Plasmon Resonance Market is Extrapolated to Reach a Value of USD 1.5 Bn by 2029 | Surface Plasmon Resonance (SPR) is a technique used to monitor label-free bimolecular interactions in real time. In this technique, one of the molecules is immobilized on metallic film. Metallic film is usually made of gold as it gives a SP... |
| 16.12.2021 | Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry | Nicoya Lifesciences, a global leader in digital proteomics solutions, today announced a $20 million Series A extension led by Whitecap Venture Partners. The round included participation from strategic investor Agilent Technologies, a leadin... |
| 14.04.2021 | Nicoya promised additional funding from federal government to develop COVID-19 test | Kitchener-Waterloo-based healthtech startup Nicoya has announced it is set to receive more financial support and advisory services from the Government of Canada to continue the research and development of its rapid, saliva-based COVID-19 an... |
| 06.04.2021 | Nicoya Lifesciences receives additional funding for next-phase development of its rapid, saliva-based COVID-19 diagnostic test | |
| 16.06.2020 | Nicoya to receive funding, advisory services through NRC IRAP to develop COVID-19 test | Kitchener-Waterloo-based healthtech startup Nicoya has been selected to receive advisory services and up to approximately $299,000 from the federal government to develop a portable COVID-19 diagnostic test called Atlas. “Atlas will fill an ... |
| 14.01.2020 | Nicoya Secures $10M in Series A Funding | Nicoya, a Kitchener, ON – based provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, raised $10m in Series A financing. The round was led by Whitecap Venture Partners with participation from exist... |
| 14.01.2020 | Daily funding roundup - January 14th, 2020 | SurvivorNet, Nicoya, Containous and Lemongrass Consulting raised 10M Spotio: Spotio is a mobile sales management platform for field sales teams. Spotio has raised $4.5 million in Series A funding from Ballast Point Ventures. More here. Read... |
| 14.01.2020 | Nicoya raises $10 million CAD to aid drug treatment development | Nicoya, a healthtech startup that has developed analytical instruments for the biotech and pharmaceutical industries, has raised $10 million CAD in Series A funding. The round was led by Whitecap Venture Partners, the Toronto-based venture ... |
| 03.05.2019 | Nanotech company Nicoya receives $2.57 million FedDev Ontario investment | Waterloo-based nanotechnology company Nicoya is receiving a $2.57 million investment from FedDev Ontario, which the government said will help scale up Nicoya’s operations and accelerate its growth into new markets. Nicoya is developing a la... |
Show more